BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 10, 2010
View Archived Issues
AGN-196923 alleviates neuropathic pain in animal models
Read More
GSK-2188931 shows promise in rat model of myocardial infarction
Read More
Prodrug delivers fenofibric acid and nitric oxide for cardiovascular disease treatment
Read More
Roche identifies new inhibitors of PDE10A
Read More
Yondelis obtains marketing authorization for ovarian cancer in Russia
Read More
MAP Pharmaceuticals provides update on Levadex clinical development program
Read More
Scientists suppress alpha-synuclein expression in primate substantia nigra using siRNA
Read More
New gamma-secretase modulators show favorable properties in preclinical evaluation
Read More
Primary endpoint met in Renovo's phase I safety studies of Juvista after keloid excision
Read More
ImmunoCellular reports long-term disease-free survival data from phase I ICT-107 trial in GBM
Read More
GSK and Genmab initiate phase III trial of ofatumumab in indolent B-NHL
Read More
Johnson & Johnson to discontinue sale of ceftobiprole for cSSTI in Switzerland
Read More
Boehringer Ingelheim presents new C-raf inhibitors
Read More
Novel SEH inhibitors disclosed by Takeda Pharmaceutical
Read More
Pulmagen Therapeutics claims new MAP kinase p38 alpha inhibitors
Read More
Vertex Pharmaceuticals describes new PI3K-gamma inhibitors
Read More
Santarus, S2 Therapeutics and VeroScience sign license agreement for Cycloset
Read More
GFT-505 shows promise as antidiabetic agent in clinical study
Read More
Curaxis presents development plan for Memryte in Alzheimer's disease
Read More
FDA requires additional time to review Questcor's H.P. Acthar sNDA
Read More
Tragara Pharma begins phase I TG-02 trial in hematological malignancies
Read More
Phase III COU-AA-301 trial of abiraterone/prednisone is unblinded due to efficacy
Read More
FDA grants Zentylor fast track status for progressive supranuclear palsy
Read More
CombinatoRx becomes Zalicus
Read More
Novartis receives first approval for Gilenya MS therapy in Russia
Read More